Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Letter
  • Published:

Complementation by the protein tyrosine kinase JAK2 of a mutant cell line defective in the interferon-& gamma; signal transduction pathway

Nature volume 366, pages 166–170 (1993)Cite this article

Abstract

INTERFERONS (IFNs) & alpha;/& beta; (type I) and & gamma; (type II) bind to distinct cell surface receptors1, inducing transcription of overlapping sets of genes by intracellular pathways that have recently attracted much attention2,3. Previous studies using cell lines selected for their inability to respond to IFN-& alpha; (ref. 4) have shown that the protein kinase Tyk2 plays a central role in the IFN & alpha;/& beta; response5. Here we report the isolation of the cell line & gamma;l A, selected for its inability to express IFN-& gamma;-inducible cell-surface markers, that is deficient in all aspects of the IFN-& gamma; response tested, but responds normally to IFNs & alpha; and & beta;. The mutant cells can be complemented by the expression of another member of the JAK family of protein tyro-sine kinases, JAK2 (refs 6& ndash;9). Unlike IFNs & alpha; and & beta;, IFN-& gamma; induces rapid tyrosine phosphorylation of JAK2 in wild-type cells, and JAK2 immunoprecipitates from these cells show tyrosine kinase activity. These responses are absent in & gamma;l A cells. JAK2 is therefore required for the response to IFN-& gamma; but not to IFNs & alpha; and & beta;.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on SpringerLink
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Similar content being viewed by others

References

  1. Pestka, S., Langer, T. A., Zoon, K. C. & Samuel, C. E. A. Rev. Biochem. 56, 727–777 (1987).

    Article  CAS  Google Scholar 

  2. Pellegrini, S. & Schindler, C. Trends biochem. Sci. 18, 338–342 (1993).

    Article  CAS  Google Scholar 

  3. Müller, M. et al. Nature 366, 129–135 (1993).

    Article  ADS  Google Scholar 

  4. Pellegrini, S., John, J., Shearer, M., Kerr, I. M. & Stark, G. R. Molec. cell. Biol. 9, 4605–4612 (1989).

    Article  CAS  Google Scholar 

  5. Velazquez, L., Fellous, M., Stark, G. R. & Pellegrini, S. Cell 70, 313–322 (1992).

    Article  CAS  Google Scholar 

  6. Wilks, A. F. et al. Molec. cell. Biol. 11, 2057–2065 (1991).

    Article  CAS  Google Scholar 

  7. Harpur, A. G., Andres, A-C., Ziemiecki, A., Aston, R. R. & Wilks, A. F. Oncogene 7, 1347–1353 (1992).

    CAS  PubMed  Google Scholar 

  8. Firmbach-Kraft, I., Byers, M., Shows, T., Dalla-Favera, R. & Krolewski, J. J. Oncogene 5, 1328–1336 (1990).

    Google Scholar 

  9. Silvennoinen, O. et al. Proc. natn. Acad. Sci. U.S.A. 90, 8429–8433 (1993).

    Article  ADS  CAS  Google Scholar 

  10. Reid, L. E. et al. Proc. natn. Acad. Sci. U.S.A. 86, 840–844 (1989).

    Article  ADS  CAS  Google Scholar 

  11. Sewel, W. A., Brown, M. H., Dunne, J. & Owen, M. Proc. natn. Acad. Sci. U.S.A. 83, 8718–8722 (1986).

    Article  ADS  Google Scholar 

  12. Schindler, C., Shuai, K., Prezioso, V. R. & Darnell, J. E. Jr Science 257, 809–813 (1992).

    Article  ADS  CAS  Google Scholar 

  13. Shuai, K., Schindler, C., Prezioso, V. R. & Darnell, J. E. Jr Science 258, 1808–1812 (1992).

    Article  ADS  CAS  Google Scholar 

  14. Müller, M. et al. EMBO J. 12, 4221–4228 (1993).

    Article  Google Scholar 

  15. Decker, T., Lew, D. J., Mirkovitch, J. & Darnell, J. E. Jr EMBO J. 10, 927–932 (1991).

    Article  CAS  Google Scholar 

  16. Kanno, Y. et al. Molec. cell. Biol. 13, 3951–3963 (1993).

    Article  CAS  Google Scholar 

  17. Pearse, R. N., Feinman, R., Shuai, K., Darnell, J. E. Jr & Ravetch, J. V. Proc. natn. Acad. Sci. U.S.A. 90, 4314–4318 (1993).

    Article  ADS  CAS  Google Scholar 

  18. Khan, K. D. et al. Proc. natn. Acad. Sci. U.S.A. 90, 6806–6810 (1993).

    Article  ADS  CAS  Google Scholar 

  19. Perez, C., Wietzerbin, J. & Benech, P. D. Molec. cell. Biol. 13, 2182–2192 (1993).

    Article  CAS  Google Scholar 

  20. Witthuhn, B. A. et al. Cell 74, 227–236 (1993).

    Article  CAS  Google Scholar 

  21. Argetsinger, L. S. et al. Cell 74, 237–244 (1993).

    Article  CAS  Google Scholar 

  22. Stahl, N. & Yancopolous, G. D. Cell 74, 587–590 (1993).

    Article  CAS  Google Scholar 

  23. Larner, A. C. et al. Science 261, 1730–1733 (1993).

    Article  ADS  CAS  Google Scholar 

  24. Igarishi, K-I., David, M., Larner, A. C. & Finbloom, D. S. Molec. cell. Biol. 13, 3984–3989 (1993).

    Article  Google Scholar 

  25. Morgenstern, J. P. & Land, H. Nucleic Acids Res. 18, 1068 (1990).

    Article  CAS  Google Scholar 

  26. Farrar, M. A., Campbell, J. D. & Schrieber, R. D. Proc. natn. Acad. Sci. U.S.A. 89, 11706–11710 (1992).

    Article  ADS  CAS  Google Scholar 

  27. Cook, J. R., Jung, V., Schwartz, B., Wang, P. & Pestka, S. Proc. natn. Acad. Sci. U.S.A. 89, 11317–11321 (1992).

    Article  ADS  CAS  Google Scholar 

Download references

Author information

Author notes

  1. Olli Silvennoinen: Department of Pharmacology, New York University Medical Center, New York, New York 10016, USA

  2. Bruce A. Witthuhn, Frederick W. Quelle and James N. Ihle: Department of Biochemistry, St Jude Children's Research Hospital, 332 North Lauderdale, Memphis, Tennessee 38101-0318, USA

  3. Chris Schindler: Department of Molecular Medicine, Columbia University Medical Center, New York, New York 10032, USA

  4. George R. Stark: Department of Molecular Biology, Cleveland Clinic Foundation Research Institute, 9500 Euclid Avenue, Cleveland, Ohio 44195-5001. USA

Authors and Affiliations

  1. Imperial Cancer Research Fund, 44 Lincoln's Inn Fields, London, WC2A 3PX, UK

    Diane Watling, Dmitry Guschin, Mathias Müller, Olli Silvennoinen, Bruce A. Witthuhn, Frederick W. Quelle, Neil C. Rogers, Chris Schindler, George R. Stark, James N. Ihle & lan M. Kerr

Authors
  1. Diane Watling
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Dmitry Guschin
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Mathias Müller
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Olli Silvennoinen
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Bruce A. Witthuhn
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Frederick W. Quelle
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Neil C. Rogers
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Chris Schindler
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. George R. Stark
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. James N. Ihle
    View author publications

    You can also search for this author in PubMed Google Scholar

  11. lan M. Kerr
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Watling, D., Guschin, D., Müller, M. et al. Complementation by the protein tyrosine kinase JAK2 of a mutant cell line defective in the interferon-& gamma; signal transduction pathway. Nature 366, 166–170 (1993). https://doi.org/10.1038/366166a0

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1038/366166a0

This article is cited by

Search

Advanced search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing